CN1095615A - Externally-used agent for treatment of psoriasis - Google Patents

Externally-used agent for treatment of psoriasis Download PDF

Info

Publication number
CN1095615A
CN1095615A CN 93118088 CN93118088A CN1095615A CN 1095615 A CN1095615 A CN 1095615A CN 93118088 CN93118088 CN 93118088 CN 93118088 A CN93118088 A CN 93118088A CN 1095615 A CN1095615 A CN 1095615A
Authority
CN
China
Prior art keywords
psoriasis
external agent
substrate
good
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93118088
Other languages
Chinese (zh)
Inventor
卢兰亭
卢云飞
任智勇
Original Assignee
卢兰亭
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 卢兰亭 filed Critical 卢兰亭
Priority to CN 93118088 priority Critical patent/CN1095615A/en
Publication of CN1095615A publication Critical patent/CN1095615A/en
Pending legal-status Critical Current

Links

Abstract

What the present invention relates to is a kind of medicine that is used for the treatment of refractory skins such as psoriasis.Its basic effective constituents is: Chinese and Western medical materials such as Radix Panacis Quinquefolii, hydrocortisone, Calomelas, Os Draconis, Calamina, salicylic acid, sulfur, phenol, with their powder and substrate, make various external agent products.The present invention offers medicine simply, fills a prescription unique, makes easily; Good effect, safe and reliable, have no side effect effective percentage 100%, cure rate is more than 90%, and the scope of application is wide, good economy performance, whatsoever this preparation of psoriasis of type all has good effectiveness, can alleviate significantly the patient pain and if financial burden, obvious social benefit.

Description

Externally-used agent for treatment of psoriasis
What the present invention relates to is a kind of medicine that is used for the treatment of refractory skins such as psoriasis.
Psoriasis is one of four big pertinacious diseases of being known as world's end solution still.This refractory skin makes the patient taste varieties of misery, extremely decocts torment.Be used for the treatment of the effective medicine for external use of refractory skin such as psoriasis at present, as anthralin Ointment, chlorine fluorine Shu Shuan etc., generally all formed by substrate and active ingredient modulation, select for use different substrate to can be formulated into different cream, frost (breast) dosage form, chemical substance is almost adopted in active ingredient entirely.The weak point of these existing common drugs mainly is: curative effect is all not ideal enough, easily recurrence after the drug withdrawal, and Western medicine, the side effect of chemicals life-time service are big, and what have contains a large amount of hormones; In addition, also there is narrow application range in the medicine that has, and what have is only effective to certain several types in the psoriasis, not suitable to other type, not only invalid, increases the weight of on the contrary sometimes after the use; Though have effectively curative effect is slow, the course of treatment long, need just can manifest effect more than half a year to one year, these certainly will make patient economy burden overweight.
The objective of the invention is to avoid the deficiencies in the prior art part, and a kind of good effect is provided, short treating period is in having no side effect, the psoriasis external agent product formed of Western medicine.
Can take following technical scheme to realize purpose, it is also formed by substrate and effective ingredient allotment, but active ingredient is made up of Radix Panacis Quinquefolii, hydrocortisone, Calomelas, Os Draconis, Calamina, salicylic acid, sulfur, phenol substantially, and the consumption of every component can be selected as one sees fit.Medical material through clean, dry, pulverization process becomes 80-120 order fine powdered, active ingredient and substrate are mixed in proportion promptly can be made into to the specific various external agent products of refractory skins such as psoriasis.
Be described in further detail in conjunction with the content of embodiment the technical program.
During Chinese and Western medical material in this psoriasis external agent can be pressed, the conventional amount used of doctor trained in Western medicine is selected, or suitably increase and decrease contains the external agent of these basic effective constituents, all has heat clearing away, removing heat from blood, invigorates blood circulation, nourishes blood, the circulation of qi promoting skin moistening; The obvious effect of desensitization antiinflammatory, antipruritic, desquamation, this is the unique distinction of this preparation just.As for substrate, can adopt vaseline or ethanol or edible oil or Mel or paraffin etc. to make different dosage forms routinely, as cream, water ...Also can mix lanoline in substrate on a small quantity increases the medicine penetration power, play soften, effect such as suction.No matter make which kind of dosage form, basic active ingredient wherein is constant, just refractory skins such as psoriasis is had obvious curative effects.
When the consumption of basic effective constituents is respectively by total weight:
Radix Panacis Quinquefolii 2-3% hydrocortisone 0.1-0.2%
Calomelas 0.1-0.2% Os Draconis 5-20%
Calamina 5-20% salicylic acid 3-5%
Sulfur 3-5% phenol 1-2%;
Made cream during with substrate 50-70% weight, water ..., be good through the clinic trial curative effect.
Also can in above-mentioned effective ingredient, camphorate, Borneolum Syntheticum or other Chinese crude drug adapt to the state of an illness, improves curative effect.Their consumption is Camphora 1-2% by weight, the best during Borneolum Syntheticum 9.8-9.9%.
Used medical material all can be bought from pharmaceuticals or pharmaceutical factory.What wherein Radix Panacis Quinquefolii employing life in 3 years was above is good.The external agent can evenly be coated with one deck by 3 times/day or doctor's advice and get final product in the affected part.
Can prepare psoriasis external agent by the following method:
A, washing: the medical material that will need to wash is removed earth impurity, is cleaned up.To can directly buy, satisfactory powder then need not to carry out other processing.
B, drying: washed medical material is carried out dried, but to degree of grinding.But artificial drying or natural air drying.
C, pulverizing: will be through the pulverizing medicinal materials of above-mentioned processing to the 80-120 order.
D, mixing: due active ingredient and substrate are concerned mix homogeneously in proportion, promptly get psoriasis external agent.Should do different processing routinely to different substrate during mixing, as when adopting vaseline and lanoline,, put after the fusing when being chilled to 40 ℃ of left and right sides earlier with vaseline, lanoline Hybrid Heating as substrate, slowly add each effective ingredient, stirring is psoriasis paster.
Adopt medical general drying plant during preparation, pulverizer, blender, pack, bottle filling machine just can meet the demands, and need not other special installation.
Example 1:(presses % weight)
Radix Panacis Quinquefolii 3
Hydrocortisone 0.2
Calomelas 0.1
Os Draconis 6.8
Calamina 5
Salicylic acid 4
Sulfur 5
Phenol 1
Camphora 1
Borneolum Syntheticum 9.8
70% ethanol 64.1
The water preparation that makes except that to each parapsoriasis effectively, to controlling the head psoriasis specially good effect is arranged.
Example 2:(presses % weight)
Radix Panacis Quinquefolii 3
Hydrocortisone 0.2
Calomelas 0.2
Os Draconis 6.8
Calamina 10.8
Salicylic acid 5
Sulfur 5
Phenol 1
Vaseline 6.8
The unguentum that makes has specially good effect to the refractory skins of locating beyond the head such as psoriasis.
The relatively existing topical drug of the present invention has following advantage:
1, dispensing is simple, and prescription is unique, the Chinese and Western medicine combination, and take Chinese medicine as main, technology is simple, makes easily.
2, good effect, safe and reliable has no side effect: the fast short treating period of curative effect, and general medication 10-20 days can take effect, and with the same usefulness of psoriasis oral agents, recovery from illness 1-3 month course of treatment can not recurred substantially, effective percentage 100%, cure rate is more than 90%.The patient of more than ten years tries out psoriasis external agent, the recovery from illness in two months of psoriasis oral agents, and not recurrence in 5 years is described as the psoriasis specific drug by the trier so far.
3, wide, the good economy performance of the scope of application: the homeliness type of types such as this external agent is dry to heat in blood, the blood of the traditional Chinese medical science, blood stasis, doctor trained in Western medicine, joint type, pustular type etc., whatsoever this preparation of psoriasis of type all has good effectiveness, can significantly alleviate patient's misery and financial burden, obvious social benefit.

Claims (5)

1, a kind of psoriasis external agent is formed by substrate and effective ingredient allotment, it is characterized in that its basic active ingredient is: Radix Panacis Quinquefolii, hydrocortisone, Calomelas, Os Draconis, Calamina, salicylic acid, sulfur, phenol.
2, psoriasis external agent as claimed in claim 1 is characterized in that it also can camphorate, the Borneolum Syntheticum active ingredient.
3, psoriasis external agent as claimed in claim 1 is characterized in that the consumption of active ingredient is respectively by total weight:
Radix Panacis Quinquefolii 2-3% hydrocortisone 0.1-0.2%
Calomelas 0.1-0.2% Os Draconis 5-20%
Calamina 5-20% salicylic acid 3-5%
Sulfur 3-5% phenol 1-2%
Substrate 50-70% weight.
4, psoriasis external agent as claimed in claim 2 is characterized in that by weight: Camphora 1-2%, Borneolum Syntheticum 9.8-9.9%.
5, as claim 1,2 described psoriasis external agent, it is characterized in that its substrate can adopt vaseline, ethanol, edible oil, Mel, paraffin etc.
CN 93118088 1993-09-30 1993-09-30 Externally-used agent for treatment of psoriasis Pending CN1095615A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93118088 CN1095615A (en) 1993-09-30 1993-09-30 Externally-used agent for treatment of psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93118088 CN1095615A (en) 1993-09-30 1993-09-30 Externally-used agent for treatment of psoriasis

Publications (1)

Publication Number Publication Date
CN1095615A true CN1095615A (en) 1994-11-30

Family

ID=4992332

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93118088 Pending CN1095615A (en) 1993-09-30 1993-09-30 Externally-used agent for treatment of psoriasis

Country Status (1)

Country Link
CN (1) CN1095615A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479058B1 (en) * 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
CN104173396A (en) * 2014-07-25 2014-12-03 中国人民解放军第三0二医院 Dracontomelon duperreanum leaf extract suspension, as well as preparation method and application thereof
CN111773356A (en) * 2020-08-06 2020-10-16 辽宁宝一堂科技发展有限公司 Preparation method of plaster for treating psoriasis

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479058B1 (en) * 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6890544B2 (en) 1999-09-02 2005-05-10 Mccadden Michael E. Gel composition for the topical treatment of poison ivy and other forms of contact dermatitis
CN104173396A (en) * 2014-07-25 2014-12-03 中国人民解放军第三0二医院 Dracontomelon duperreanum leaf extract suspension, as well as preparation method and application thereof
CN104173396B (en) * 2014-07-25 2017-09-26 中国人民解放军第三0二医院 Dracontomelon duperreanum leaf extract supensoid agent and preparation method and application
CN111773356A (en) * 2020-08-06 2020-10-16 辽宁宝一堂科技发展有限公司 Preparation method of plaster for treating psoriasis

Similar Documents

Publication Publication Date Title
US5165932A (en) Therapeutical compositions against psoriasis
CN102018661A (en) External preparation for resisting funguses and preparation method of external preparation
CN1095615A (en) Externally-used agent for treatment of psoriasis
CN1052420C (en) Chinese medicine for curing burn and traumatic wound and its production method
US4515779A (en) Skin tumor removal and healing compositions and processes
CN1055004C (en) Enternal use adhesive plaster for treatment of rheumatism
CN1177490A (en) Oil ointment of chirita longangensis for treating burns
CN1060955C (en) Plaster for treating wound
CN1435225A (en) Medical ointment Jiaoxuanxiao for treating beriberi
CN1089497A (en) Multi-effect compound ointment for trauma
CN1038477C (en) Oral liquor for treatment of psoriasis
CN1057213C (en) Chinese medicinal preparation for treatment skin disease and its prepn. method
CN1086955C (en) Ointment for treating burn and scald and its preparing process
CN1216625C (en) Ointment for treating beriberi and its preparing method
RU2107510C1 (en) "labunik" ointment and for treating skin diseases
CN1296035C (en) Beauty-care medicinal cream for eliminating wrinkle and freckle contg. snakegourd fruit
CN1709354A (en) Injection agent of cordate houttuynia and honeysuckle and its preparing method
CN1097601A (en) The medicine and the preparation technology thereof of treatment tinea pedis
CN107050059A (en) Jiaoqiling for beriberi nanometer emulsifiable paste
CN102872169B (en) Medicine composition for treating chronic rhinitis and preparation method of medicine composition
US11666622B2 (en) Topical treatment for animals
CN114246912B (en) Itching relieving composition containing sugarcane leaves and star anise leaves and preparation method thereof
CN105920103A (en) External spray for treating dermatophytosis and preparation method thereof
CN107485647A (en) Blue cream and its production method
CN110859851A (en) Antifungal spray and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication